Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Reduction in Platelet Counts May Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

Blood (2024) 144 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2024-202937

Published: 2024

Journal Articles

BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study

Tsila Zuckerman, MD, Ron Ram, MD, Maya Koren-Michowitz, MD, Luiza Akria, MD, Ron Hoffman, Israel Henig, MD, Yishai Ofran, MD, Noa Lavi, MD, Netanel A Horowitz, MD, Olga Nudelman, MD, Shay Yeganeh, MD, Stela Gengrinovitch, PhD, Liat Flaishon, PhD MD, Ruth Ben Yakar, PhD, Jacob M. Rowe, MD

Blood (2017) 130 (Supplement 1): 893.

https://doi.org/10.1182/blood.V130.Suppl_1.893.893

Published: 2017

Journal Articles

Astarabine, a Novel Leukemia-Targeted Cytarabine Composition Allows, for the First Time, the Delivery of High Cytarabine Doses for Older or Unfit Patients with Acute Leukemia. Results of an Ongoing Phase I/IIa Study

Tsila Zuckerman, MD, Stela Gengrinovitch, PhD, Ruth Ben-Yakar, PhD, Ron Hoffman, MD, Israel Henig, MD, Noa Lavi, MD, Luiza Akria, MD, Yishai Ofran, MD, Netanel A Horowitz, MD, Olga Nudelman, MD, Maya Koren-Michowitz, MD, Shay Yeganeh, MD, Martin S. Tallman, MD, Jacob M. Rowe, MD

Blood (2016) 128 (22): 1650.

https://doi.org/10.1182/blood.V128.22.1650.1650

Published: 2016

Journal Articles

Astarabine, a Pro-Drug of Cytarabine, Is Safe for Patients with Advanced Acute Leukemia. A Phase I/IIa Single Center Study in Relapsed/Refractory or Medically Unfit Patients

Tsila Zuckerman, MD, Ruth Ben Yakar, PhD, Stela Gengrinovitch, PhD, Ron Hoffman, MD, Israel Henig, MD, Noa Lavi, MD, Luiza Akria, MD, Yishai Ofran, MD, Olga Nudelman, MD, Nuhad Haddad, MD, Martin S Tallman, MD, Jacob M. Rowe, MD

Blood (2015) 126 (23): 3810.

https://doi.org/10.1182/blood.V126.23.3810.3810

Published: 2015

Journal Articles

Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response

Blood (2013) 122 (21): 3893.

https://doi.org/10.1182/blood.V122.21.3893.3893

Published: 2013

Journal Articles

Massive Transfusion in Wartime: Experience from Northern Israel, Summer 2006.

Eldad J. Dann, MD, Najib Dally, MD, Judith Chezar, PhD, Moshe Michaelson, MD, Mirit Barzelay, Andrei Braester, MD, Ron Hoffman, MD, Lilach Bonstein, PhD

Blood (2007) 110 (11): 4017.

https://doi.org/10.1182/blood.V110.11.4017.4017

Published: 2007

Journal Articles

CA-125 as a Marker for the Early Diagnosis of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation.

Tsila Zuckerman, MD, Shani Ben Harush, MD, Irit Avivi, MD, Israel Gavish, MD, Nuhad Haddad, MD, Riva Fineman, MD, Eldad Dann, MD, Ron Hoffman, MD, Benjamin Brenner, MD, Jacob M. Rowe, MD, Eli Zuckerman, MD

Blood (2004) 104 (11): 1138.

https://doi.org/10.1182/blood.V104.11.1138.1138

Published: 2004

Journal Articles

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

Steven M. Devine, Carrington Cobbs, Matt Jennings, Amelia Bartholomew, Ron Hoffman

Blood (2003) 101 (8): 2999–3001.

https://doi.org/10.1182/blood-2002-06-1830

Published: 2003

Journal Articles

Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients

Dana G. Wolf, Nell S. Lurain, Tsila Zuckerman, Ron Hoffman, Judith Satinger, Alik Honigman, Niveen Saleh, Emanuel S. Robert, Jacob M. Rowe, Zipora Kra-Oz

Blood (2003) 101 (2): 463–465.

https://doi.org/10.1182/blood-2002-07-1982

Published: 2003

Journal Articles

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

Steven M. Devine, Ron Hoffman, Amit Verma, Rajul Shah, Basil A. Bradlow, Wendy Stock, Vera Maynard, Ellen Jessop, David Peace, Marianne Huml, Deana Thomason, Yi-Hsiang Chen, Koen van Besien

Blood (2002) 99 (6): 2255–2258.

https://doi.org/10.1182/blood.V99.6.2255

Published: 2002

Journal Articles

Role of Members of the Wnt Gene Family in Human Hematopoiesis

David J. Van Den Berg, Arun K. Sharma, Edward Bruno, Ron Hoffman

Blood (1998) 92 (9): 3189–3202.

https://doi.org/10.1182/blood.V92.9.3189

Published: 1998

Journal Articles

The Characterization, Molecular Cloning, and Expression of a Novel Hematopoietic Cell Antigen From CD34 + Human Bone Marrow Cells

Blood (1997) 89 (8): 2706–2716.

https://doi.org/10.1182/blood.V89.8.2706

Published: 1997

NARROW

Reduction in Platelet Counts May Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study

Astarabine, a Novel Leukemia-Targeted Cytarabine Composition Allows, for the First Time, the Delivery of High Cytarabine Doses for Older or Unfit Patients with Acute Leukemia. Results of an Ongoing Phase I/IIa Study

Astarabine, a Pro-Drug of Cytarabine, Is Safe for Patients with Advanced Acute Leukemia. A Phase I/IIa Single Center Study in Relapsed/Refractory or Medically Unfit Patients

Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response

Massive Transfusion in Wartime: Experience from Northern Israel, Summer 2006.

CA-125 as a Marker for the Early Diagnosis of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation.

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

Role of Members of the Wnt Gene Family in Human Hematopoiesis

The Characterization, Molecular Cloning, and Expression of a Novel Hematopoietic Cell Antigen From CD34 + Human Bone Marrow Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only